Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid discusses the latest clinical data on and optimal integration of PARP inhibitors in ovarian cancer.
CME information and select publications here.
Top comments
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.